Chill Brands Chill Brands published a ‘trading update’ to investors this morning, revealing growth in a number of key
Jazz Pharmaceuticals Epidiolex (Epidyolex in the EU and UK), Jazz Pharmaceuticals’ market leading cannabis-based medication, has received authorisation to
Cantourage Cantourage Group reported its Q3 financial figures this week, celebrating ‘significant revenue growth’ so far in 2023, but
 Celadon Pharmaceuticals This morning (November 16), AIM-listed medical cannabis operator Celadon Pharmaceuticals announced that it has signed a
Ananda Developments Aquis Stock Exchange-listed UK cannabis company Ananda Developments announced a number of key developments across both of
MGC Pharmaceuticals MGC Pharmaceuticals announced this week that it has now secured ‘binding commitments’ for US$7.9m in investment, which
Israeli Cannabis Industry A number of Israel’s leading cannabis companies have issued updates regarding the rapidly evolving situation in the
Northern Leaf Jersey-based medical cannabis cultivator Northern Leaf have said they are ‘very confident’ of launching an AIM listing in
Yooma Wellness Yooma Wellness this week announced that it had sold its last remaining revenue-generating asset as it warned that
MGC Pharmaceuticals MGC Pharmaceuticals, which became the first cannabis company to list on the London Stock Exchange (LSE) in
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.